Venlafaxine (37.5 - 225 mg/day depending on the weight) will be administered once a day according to the predefined dose escalation schedule. Participants unable to tolerate the minimum daily dose for
Sponsors
Brydun Andrey
Conditions
Major Depressive Disorder and Persistent Depressive Disorder
Phase 3
A placebo-controlled, randomized, double-blind, multicenter study of venlafaxine in Japanese pediatric patients with MDD or PDD.
RecruitingJPRN-jRCT2031220238
Start: 2023-03-22Target: 160Updated: 2026-06-29
Venlafaxine long-term extension in MDD or PDD who completed study VENL-CAZ-3001
RecruitingJPRN-jRCT2031220357
Start: 2023-06-01Target: 145Updated: 2026-06-29